Madhav Vasanthavada
About Madhav Vasanthavada
Madhav Vasanthavada is a seasoned pharmaceutical executive with a strong background in both scientific research and business management.
Senior Vice President and Chief Commercial Officer
Madhav Vasanthavada currently serves as the Senior Vice President, Chief Commercial Officer, and Head of Business Development. In his role, he is responsible for overseeing commercial strategies and business development initiatives, ensuring the company's growth and market presence. His leadership in these areas is pivotal for driving business goals and achieving market expansions.
Educational Background in Pharmaceutical Sciences and Business Administration
Madhav Vasanthavada holds a Ph.D. in Pharmaceutical Sciences from the University of Rhode Island. This academic foundation provides him with an in-depth understanding of pharmaceutical research and development. Additionally, he earned an M.B.A. from Harvard Business School, equipping him with robust business acumen and strategic management skills. This unique combination of qualifications bolsters his ability to navigate and lead within the pharmaceutical industry.
Previous Leadership in CAR-T Cell Therapy Franchise
Before his current role, Madhav Vasanthavada led the marketing team in the Global CAR-T Cell Therapy Franchise at Bristol Myers Squibb and Celgene. His responsibilities included developing and executing marketing strategies for advanced cell therapies. His leadership contributed to the effective commercialization and competitive positioning of CAR-T cell therapy products in the global market.
Brand Leadership Experience at Bayer
Madhav Vasanthavada's expertise extends to his tenure as the brand leader for Xofigo at Bayer. In this role, he was instrumental in managing the brand's strategy and growth. His work was critical in enhancing the market penetration and recognition of Xofigo, a therapeutic radiopharmaceutical used in cancer treatment.
Scientific Contributions at Novartis R&D
Madhav Vasanthavada began his career as a scientist in the research and development division at Novartis. His work there led to the development of multiple patents and publications, showcasing his capability to innovate and contribute to pharmaceutical research. His scientific background provides a strong foundation for his subsequent roles in the commercial and strategic domains of the pharmaceutical industry.